Health
Foresight Diagnostics demonstrates the benefits of PhasED-Seq technology at the ICML meeting – News-Medical.Net – Fior Reports
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical…
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical performance of its Minimal Residual Disease Detection Platform (MRD) in Diffuse B-Cell Large Cell Lymphoma (DLBCL) will be presented…
Continue Reading
-
General13 hours ago‘We are here for you’: PM to bring help to flood zones
-
Noosa News23 hours agoPolice to get on-the-spot protection powers for DV victims
-
General11 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News11 hours agoRates on hold; pressure builds for cuts in May